Instrument Inactif

Autres langues Norda ASA Oslo Bors

Actions

NORD

NO0010285190

Recherche biotechnologique et médicale

Autres langues

17/06	Norda ASA announces Annual dividend, payable on June 25, 2026
09/04	Exercise of Warrants by primary insiders
10/07/25	Mandatory Notification of Trade
04/06/25	Ocean Sun: Mandatory notification of trade
13/05/25	Norda ASA announces Annual dividend, payable on May 22, 2025
06/05/25	Norda ASA Reports Earnings Results for the Full Year Ended December 31, 2024
27/03/25	Nykode Therapeutics - Mandatory Notification of Trade by Closely Associated Party of a Primary Insider
03/03/25	Notification of trade
03/03/25	Disclosure of large shareholding in Gentian Diagnotics ASA
10/01/25	Morrow Bank ASA - Disclosure of Large Shareholding
08/11/24	Nykode Therapeutics ASA - Mandatory Notification of Trade by Closely Associated Party of a Primary Insider
08/11/24	Disclosure of large shareholding in Nykode Therapeutics ASA
01/11/23	Norda ASA Reports Earnings Results for the Full Year Ended December 31, 2022
16/03/23	Trail-running Tipped To Be Activewear's Next Big Thing
16/06/22	Norda ASA Reports Earnings Results for the Full Year Ended December 31, 2021
21/06/21	Norda Asa Reports Earnings Results for the Full Year Ended December 31, 2020
26/05/21	Nordhealth AS: Primary insider notice
25/05/21	Nordhealth AS: Private placement successfully completed
22/05/13	Norda ASA Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2013
09/04/13	Norda ASA Reports Unaudited Net Debt Results as of December 31, 2012
09/04/13	Norda ASA Appoints Scient Frode Westvold as CEO
28/02/13	Norda ASA Reports Unaudited Earnings Results for the Fourth Quarter and Year Ended December 31, 2012
31/10/12	Norda ASA Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2012
12/10/12	Norda ASA Obtains NOK 35 Million Line of Credit from a Norwegian Bank
29/08/12	Norda ASA Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2012